Lazard US Equity Concntr B Acc EUR H |
Performance History | 30/04/2024 |
Growth of 1,000 (EUR) |
Fund | 8.5 | 22.9 | -22.8 | 11.1 | -3.1 | |
+/-Cat | - | - | - | - | - | |
+/-Idx | - | - | - | - | - | |
Category: Other Equity | ||||||
Benchmarks: - |
Key Stats | ||
NAV 30/04/2024 | EUR 131.06 | |
Day Change | -1.88% | |
Morningstar Category™ | Other Equity | |
ISIN | IE00BYQ4FW05 | |
Fund Size (Mil) 30/04/2024 | USD 163.31 | |
Share Class Size (Mil) 30/04/2024 | EUR 0.17 | |
Max Initial Charge | 5.00% | |
Ongoing Charge 11/01/2024 | 1.60% |
Investment Objective: Lazard US Equity Concntr B Acc EUR H |
The Fund is an all-cap, concentrated fund that seeks long-term capital appreciation. It is benchmark agnostic, seeking to outperform any broad-based US index (i.e., S&P 500 Index, Russell 1000 Index, Russell 3000 Index) by investing in financially productive (e.g., high return on equity, free cash flow, cash flow return on investment) companies across the market capitalization spectrum, employing intensive fundamental analysis and accounting validation to identify investment opportunities. The Fund typically invests in 15–35 companies with market capitalizations generally greater than $350 million. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Martin Flood 25/02/2016 | ||
Jay Levy 31/03/2022 | ||
Click here to see others | ||
Inception Date 27/10/2017 |
Advertisement |
Benchmarks | |
Fund Benchmark | Morningstar Benchmark |
S&P 500 NR USD | - |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Lazard US Equity Concntr B Acc EUR H | 31/03/2024 |
|
|
Top 5 Holdings | Sector | % |
Laboratory Corp of America Holdings | Healthcare | 8.85 |
Alphabet Inc Class A | Communication Services | 8.11 |
Fidelity National Information Se... | Technology | 6.65 |
S&P Global Inc | Financial Services | 6.47 |
Crown Castle Inc | Real Estate | 5.86 |
Increase Decrease New since last portfolio | ||
Lazard US Equity Concntr B Acc EUR H |